Group 1 - The core viewpoint of the articles highlights Samsung Medical's current stock performance, with a closing price of 26.0 yuan, down 3.70%, and a rolling PE ratio of 16.45 times, indicating a lower valuation compared to the industry average [1] - Samsung Medical's total market capitalization stands at 36.686 billion yuan, ranking 33rd in the electric grid equipment industry, which has an average PE ratio of 34.38 times and a median of 33.38 times [1][2] - As of the third quarter of 2024, 618 institutions hold shares in Samsung Medical, with a total holding of 22,478.70 million shares valued at 6.914 billion yuan [1] Group 2 - The main business of Ningbo Samsung Medical Electric Co., Ltd. includes smart power distribution and medical services, with key products being smart electricity products and solutions, smart distribution products and systems, and new energy products [1] - The company has received several accolades, including being recognized as a national-level intellectual property demonstration enterprise and having subsidiaries awarded as national-level intellectual property advantageous enterprises [1] - For the latest financial performance, Samsung Medical reported operating revenue of 10.434 billion yuan, a year-on-year increase of 25.14%, and a net profit of 1.816 billion yuan, up 21.91%, with a gross profit margin of 36.21% [1]